Female Estrous Cycle Influences How Well GLP-1 Drugs Suppress Appetite in Rats | Research

The takeaway

The estrous cycle modulates GLP-1 RA effects on food intake and body weight in female rats, with implications for sex-specific dosing strategies.

Cycle-dependent efficacy
GLP-1 RA appetite suppression varies with estrous cycle phase in female rats

What the researchers found

The estrous cycle moderates GLP-1 RA effects on food intake and body weight, with brainstem GLP-1 receptor expression varying across cycle phases.

Why it matters

If menstrual cycle phase affects GLP-1 drug efficacy in women, this could explain variable weight loss responses and potentially inform sex-specific dosing.

How the study worked

Preclinical study in female rats examining GLP-1 RA efficacy across estrous cycle phases, with brainstem gene expression analysis of Glp1r and Gcg.

What this study cannot tell us

Animal model — rat estrous cycles are shorter and simpler than human menstrual cycles; direct translation to women needs clinical validation.

How to read the evidence

Preclinical animal study — important mechanistic insight but requires human clinical validation.

When this study was published

Published 2026 in Diabetes, Obesity & Metabolism.

The bigger picture

Sex-specific pharmacology is increasingly recognized as important. These findings add to growing evidence that drug responses in women may be modulated by hormonal cycles.

Questions still open

Do women on GLP-1 RAs report variable appetite suppression across their menstrual cycle?
Should GLP-1 RA dosing be adjusted based on menstrual cycle phase?

Common questions

Do GLP-1 drugs work differently for women?

This animal study suggests the menstrual cycle may affect how well GLP-1 drugs suppress appetite. More women than men use these drugs, making this an important area for future clinical research.

Why do most studies use male animals?

Historically, researchers avoided female animals due to hormonal variability. This study demonstrates exactly why female-specific research is necessary — hormonal cycles can significantly affect drug response.

Read the original research

The estrous cycle moderates the food and body weight suppressive effects of glucagon-like peptide-1 receptor agonism.

Diabetes, obesity & metabolism, 28(1), 221-230

View on PubMed ↗Publisher’s paper ↗

Citation

Applebey, Sarah V; Xiao, Allison G; Reiner, Benjamin C; Hayes, Matthew R. (2026). The estrous cycle moderates the food and body weight suppressive effects of glucagon-like peptide-1 receptor agonism.. Diabetes, obesity & metabolism, 28(1), 221-230. https://doi.org/10.1111/dom.70177